Skip to main content
. 2022 Aug 21;2022:9460019. doi: 10.1155/2022/9460019

Table 1.

Comparison of general characteristics.

PMC BPN PLC HPG p Value
No 16 32 80 48

Age, y ± SD 55.2 ± 8.9 56.3 ± 8.9 55.0 ± 9.2 53.2 ± 9.2 0.317

Sex, n (%) 0.587
 Male 12 (75.0) 24 (75.0) 57 (71.3) 35 (72.9)
 Female 4 (25.0) 8 (25.0) 23 (28.7) 13 (27.1)

Smoking history, n (%) 0.069
 Yes 10 (62.5%) 14 (43.8) 33 (41.3) 19 (39.6)
 No 6 (37.5%) 18 (56.2) 47 (58.7) 29 (60.4)

Comorbidity, n (%) 0.345
 Yes 7 (43.8) 13 (40.6) 27 (33.8) 15 (31.3)
 No 9 (56.2) 19 (59.4) 53 (66.2) 33 (68.2)

Tumor site, n (%)
 LUL 4 (25.0) 4 (12.5) 21 (26.2)
 LLL 3 (18.8) 6 (18.8) 12 (15.0)
 RUL 7 (43.8) 5 (15.6) 23 (28.8)
 RML 0 1 (3.1) 4 (5.0)
 RLL 1 (6.2) 12 (37.5) 12 (15.0)
 Two or more 1 (6.2) 4 (12.5) 8 (10.0)

Pathology types, n (%)
 Ad 13 (81.1) 65 (81.2)
 SC 0 10 (12.4)
 SCLC 0 2 (2.5)
 Carcinoid 0 1 (1.3)
 Carcinosarcoma 0 1 (1.3)
 LCLC 0 1 (1.3)
 ACC 1 (6.3) 0
 Others 2 (12.6) 0